Request Trial
official_portrait_of_michelle_donelan_mp
(Photo source UK Parliament website. Used under Creative Commons).
7 September 2023FeaturesPharmaSarah Speight

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

Today, the British scientific community woke to the news that the UK has finally rejoined Horizon Europe, the European Union’s €95.5 billion ($102 billion) research funding programme.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Pharma
Novartis scores UK win in high-stakes Entresto fight
14 August 2026   Pressure for generic manufacturers of the blockbuster heart drug Entresto is mounting as the Swiss pharma company secures a win over a challenge to its UK patent protection.
Pharma
Lilly mounts defence as generics circle Mounjaro and Zepbound
11 August 2026   A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.
Pharma
Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany
10 August 2026   Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

More features

Novartis scores UK win in high-stakes Entresto fight
The ‘Triple Point’ professional: Why patent success requires science, law, and technology
Lilly mounts defence as generics circle Mounjaro and Zepbound
Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany
The UPC plugs another gap in its procedural rulebook
Novo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers
Fran Salisbury: ‘There’s nothing quite like finding the missing piece’
Patent litigator joins Baker Botts in London as UPC grows in significance